Sample Preparation Products For Next Generation Sequencing Market Report 2025

This sample preparation products for next generation sequencing market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The sample preparation products for next generation sequencing market size has grown rapidly in recent years. It will grow from $36.87 billion in 2024 to $42.52 billion in 2025 at a compound annual growth rate (CAGR) of 15.3%. The growth in the historic period can be attributed to early improvements in sequencing technologies, sector investments in genomics and personalized medicine, rapid reduction in the cost of sequencing has made it more accessible for a variety of applications, growing interest in understanding genetic factors, strategic collaborations between technology providers.

The sample preparation products for next generation sequencing market size is expected to see rapid growth in the next few years. It will grow to $74.49 billion in 2029 at a compound annual growth rate (CAGR) of 15%. The growth in the forecast period can be attributed to demand for more accurate and comprehensive NGS solutions, enhanced data analysis capabilities, new and expanding applications in areas such as oncology, standards and approvals for clinical applications of NGS will impact, innovations in sequencing technology. Major trends in the forecast period include automated and high-throughput sample preparation processes, sample preparation protocols and ensuring high-quality, novel sequencing technologies, nanopore sequencing, adoption, and spur innovation in sample preparation products.

The growing demand for precision medicine is expected to drive the expansion of the market for sample preparation products used in next-generation sequencing (NGS). Precision medicine, also referred to as personalized medicine, tailors medical treatments and healthcare strategies to individual patients based on their specific genetic, environmental, and lifestyle factors. The increasing demand for precision medicine is largely attributed to the rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders. NGS sample preparation products are crucial for advancing precision medicine, as they facilitate the precise and efficient analysis of genetic data, which is essential for developing targeted therapies and improving patient outcomes in personalized healthcare. For example, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 new personalized therapies for patients with rare diseases in 2023, up from six in 2022. As a result, the growing demand for precision medicine is fueling the market for NGS sample preparation products.

Leading companies in the NGS sample preparation market are focusing on innovations such as next-generation sequencing to strengthen their competitive position. NGS is a groundbreaking technology that determines the sequence of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA), enabling the study of genetic variation and biological processes. For instance, in July 2023, QIAGEN N.V., a Germany-based provider of sample and assay technologies, launched the QIAseq Normalizer Kits. These kits provide researchers with a quick, convenient, and cost-effective method for pooling DNA libraries, ensuring high-quality results in NGS runs. The kits are compatible with QIAGEN's QIAseq library preparation solutions and other DNA/RNA preparation workflows for Illumina platforms.

In December 2023, PerkinElmer, a US-based technology company, acquired Covaris for an undisclosed sum. This acquisition will allow PerkinElmer to enhance its genomics solutions portfolio, providing more comprehensive tools for researchers in molecular biology and drug discovery while improving efficiency and precision in sample preparation for next-generation sequencing (NGS) and other applications. Covaris is a US-based company specializing in manufacturing sample preparation products for NGS, proteomics, and drug discovery applications.

Major companies operating in the sample preparation products for next generation sequencing market are Merck & Co. Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Eppendorf AG, Promega Corporation, Oxford Nanopore Technologies Ltd, Takara Bio Inc, New England Biolabs, Fluidigm Corporation, Pacific Biosciences of California Inc., Analytik Jena AG, SeraCare Life Sciences, Diagenode Inc., Zymo Research Corporation, Nugen Technologies Inc., Swift Biosciences Inc., Tecan Group Ltd.

North America was the largest region in the sample preparation products for next generation sequencing (NGS) market in 2024. The regions covered in the sample preparation products for next generation sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the sample preparation products for next generation sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Sample preparation products for next-generation sequencing (NGS) are specialized tools and reagents used to process biological materials such as DNA (deoxyribonucleic acid) or RNA (ribonucleic acid) prior to sequencing. These products ensure that the genetic material is effectively extracted, purified, and fragmented to meet the specifications of NGS platforms.

The primary categories of sample preparation products for NGS include DNA extraction, purification, and isolation products, RNA extraction, purification, and isolation products, panels, exome kits and other target enrichment products, DNA library construction or preparation products, RNA sequencing (SEQ) transcriptome and gene expression products, and small RNA NGS sample preparation products. DNA extraction, purification, and isolation products are specifically designed to extract DNA from sources such as blood, tissues, and cells. The therapeutic areas for these products include oncology, infectious diseases, and human or population genetics, with applications in biotechnology, medical, pharmaceutical, and other fields.

The sample preparation products for next generation sequencing market research report is one of a series of new reports that provides sample preparation products for next generation sequencing market statistics, including sample preparation products for next generation sequencing industry global market size, regional shares, competitors with a sample preparation products for next generation sequencing market share, detailed sample preparation products for next generation sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the sample preparation products for next generation sequencing industry. This sample preparation products for next generation sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sample preparation products for next generation sequencing market consists of sales of instruments, kits, reagents, and consumables. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.